Copyright © 2012 Karges Beate et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. N. De Roux, J. Young, M. Misrahi et al., “A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor,” New England Journal of Medicine, vol. 337, no. 22, pp. 1597–1602, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. N. De Roux, E. Genin, J. C. Carel, F. Matsuda, J. L. Chaussain, and E. Milgrom, “Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 10972–10976, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. S. B. Seminara, S. Messager, E. E. Chatzidaki et al., “The GPR54 gene as a regulator of puberty,” New England Journal of Medicine, vol. 349, no. 17, pp. 1614–1627, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. C. Dodé, J. Levilliers, J. M. Dupont et al., “Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome,” Nature Genetics, vol. 33, no. 4, pp. 463–465, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. C. Dodé, L. Teixeira, J. Levilliers et al., “Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.,” PLoS genetics, vol. 2, no. 10, article e175, 2006. View at Publisher · View at Google Scholar · View at PubMed
6. Y. M. Chan, A. De Guillebon, M. Lang-Muritano et al., “GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 28, pp. 11703–11708, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. A. K. Topaloglu, F. Reimann, M. Guclu et al., “TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction,” Nature Genetics, vol. 41, no. 3, pp. 354–358, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. S. R. Ojeda, A. Lomniczi, C. Mastronardi et al., “Minireview: the neuroendocrine regulation of puberty: Is the time ripe for a systems biology approach?” Endocrinology, vol. 147, no. 3, pp. 1166–1174, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. A. K. Roseweir and R. P. Millar, “The role of kisspeptin in the control of gonadotrophin secretion,” Human Reproduction Update, vol. 15, no. 2, pp. 203–212, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley, “Gonadotropin-releasing hormone receptors,” Endocrine Reviews, vol. 25, no. 2, pp. 235–275, 2004. View at Publisher · View at Google Scholar
11. B. Karges and N. de Roux, “Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome,” Endocrine development, vol. 8, pp. 67–80, 2005. View at Scopus
12. P. G. Crosignani, J. Collins, K. Diedrich et al., “Genetic aspects of female reproduction,” Human Reproduction Update, vol. 14, no. 4, pp. 293–307, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. G. Pinto, V. Abadie, R. Mesnage et al., “CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 10, pp. 5621–5626, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. N. Pitteloud, A. Meysing, R. Quinton et al., “Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes,” Molecular and Cellular Endocrinology, vol. 254-255, pp. 60–69, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. C. Dodé, C. Fouveaut, G. Mortier et al., “Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis,” Human mutation, vol. 28, no. 1, pp. 97–98, 2007. View at Scopus
16. R. Quinton, V. M. Duke, A. Robertson et al., “Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization,” Clinical Endocrinology, vol. 55, no. 2, pp. 163–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
17. G. P. Sykiotis, L. Plummer, V. A. Hughes et al., “Oligogenic basis of isolated gonadotropin-releasing hormone deficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 34, pp. 15140–15144, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. M. Beranova, L. M. B. Oliveira, G. Y. Bédécarrats et al., “Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1580–1588, 2001. View at Publisher · View at Google Scholar
19. B. Karges, W. Karges, and N. de Roux, “Clinical and molecular genetics of the human GnRH receptor,” Human Reproduction Update, vol. 9, no. 6, pp. 523–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
20. B. Karges, W. Karges, M. Mine et al., “Mutation Ala171Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1873–1879, 2003. View at Publisher · View at Google Scholar · View at Scopus
21. L. Chevrier, F. Guimiot, and N. de Roux, “GnRH receptor mutations in isolated gonadotropic deficiency: an update in 2011,” Molecular and Cellular Endocrinology, vol. 346, no. 1-2, pp. 21–28, 2011. View at Publisher · View at Google Scholar · View at PubMed
22. S. H. Kim, Y. Hu, S. Cadman, and P. Bouloux, “Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome,” Journal of Neuroendocrinology, vol. 20, no. 2, pp. 141–163, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. L. M. B. Oliveira, S. B. Seminara, M. Beranova et al., “The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1532–1538, 2001. View at Publisher · View at Google Scholar · View at Scopus
24. A. Beenken and M. Mohammadi, “The FGF family: biology, pathophysiology and therapy,” Nature Reviews Drug Discovery, vol. 8, no. 3, pp. 235–253, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. N. Pitteloud, J. S. Acierno Jr., A. Meysing et al., “Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 16, pp. 6281–6286, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. E. B. Trarbach, E. M. F. Costa, B. Versiani et al., “Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 4006–4012, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. N. Pitteloud, J. S. Acierno Jr., A. U. Meysing, A. A. Dwyer, F. J. Hayes, and W. F. Crowley, “Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1317–1322, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. T. Raivio, J. Falardeau, A. Dwyer et al., “Reversal of idiopathic hypogonadotropic hypogonadism,” New England Journal of Medicine, vol. 357, no. 9, pp. 863–873, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. J. Falardeau, W. C. J. Chung, A. Beenken et al., “Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice,” Journal of Clinical Investigation, vol. 118, no. 8, pp. 2822–2831, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. K. L. Ng, J. D. Li, M. Y. Cheng, F. M. Leslie, A. C. Lee, and Q. Y. Zhou, “Neuroscience: dependence of olfactory bulb neurogenesis on prokineticin 2 signaling,” Science, vol. 308, no. 5730, pp. 1923–1927, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. S. I. Matsumoto, C. Yamazaki, K. H. Masumoto et al., “Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4140–4145, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. C. Martin, R. Balasubramanian, A. A. Dwyer et al., “The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations,” Endocrine Reviews, vol. 32, no. 2, pp. 225–246, 2011. View at Publisher · View at Google Scholar · View at PubMed
33. N. Pitteloud, C. Zhang, D. Pignatelli et al., “Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 44, pp. 17447–17452, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. L. W. Cole, Y. Sidis, C. Zhang et al., “Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3551–3559, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. P. R. Kramer and S. Wray, “Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons,” Genes and Development, vol. 14, no. 14, pp. 1824–1834, 2000. View at Scopus
36. N. Pitteloud, R. Quinton, S. Pearce et al., “Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism,” Journal of Clinical Investigation, vol. 117, no. 2, pp. 457–463, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. K. Miura, J. S. Acierno Jr., and S. B. Seminara, “Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH),” Journal of Human Genetics, vol. 49, no. 5, pp. 265–268, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. N. Xu, H.-G. Kim, B. Bhagavath et al., “Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome,” Fertility and Sterility, vol. 95, no. 5, pp. 1613–1620.e7, 2011. View at Publisher · View at Google Scholar · View at PubMed
39. L. E. L. M. Vissers, C. M. A. Van Ravenswaaij, R. Admiraal et al., “Mutations in a new member of the chromodomain gene family cause CHARGE syndrome,” Nature Genetics, vol. 36, no. 9, pp. 955–957, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. H. G. Kim, I. Kurth, F. Lan et al., “Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome,” American Journal of Human Genetics, vol. 83, no. 4, pp. 511–519, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
41. M. C. J. Jongmans, C. M. A. van Ravenswaaij-Arts, N. Pitteloud et al., “CHD7 mutations in patients initially diagnosed with Kallmann syndrome—the clinical overlap with CHARGE syndrome,” Clinical Genetics, vol. 75, no. 1, pp. 65–71, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. H. G. Kim, J. W. Ahn, I. Kurth et al., “WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome,” American Journal of Human Genetics, vol. 87, no. 4, pp. 465–479, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. R. K. Semple, J. C. Achermann, J. Ellery et al., “Two novel missense mutations in G protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1849–1855, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. J. C. Pallais, Y. Bo-Abbas, N. Pitteloud, W. F. Crowley, and S. B. Seminara, “Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54,” Molecular and Cellular Endocrinology, vol. 254-255, pp. 70–77, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. R. Nimri, Y. Lebenthal, L. Lazar et al., “A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. E536–E545, 2011. View at Publisher · View at Google Scholar · View at PubMed
46. Y. Tenenbaum-Rakover, M. Commenges-Ducos, A. Iovane, C. Aumas, O. Admoni, and N. De Roux, “Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 1137–1144, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. J. Young, J. Bouligand, B. Francou et al., “TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2287–2295, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. E. Gianetti, C. Tusset, S. D. Noel et al., “TAC3/TACR3 mutations reveal preferential activation of gonadotropin- releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2857–2867, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. F. F. Chehab, M. E. Lim, and R. Lu, “Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin,” Nature Genetics, vol. 12, no. 3, pp. 318–320, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. K. Clément, C. Vaisse, N. Lahlou et al., “A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction,” Nature, vol. 392, no. 6674, pp. 398–401, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. A. Strobel, T. Issad, L. Camoin, M. Ozata, and A. D. Strosberg, “A leptin missense mutation associated with hypogonadism and morbid obesity,” Nature genetics, vol. 18, no. 3, pp. 213–215, 1998. View at Scopus
52. P. Fischer-Posovszky, J. Von Schnurbein, B. Moepps et al., “A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2836–2840, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. J. Licinio, S. Caglayan, M. Ozata et al., “Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4531–4536, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
54. C. K. Welt, J. L. Chan, J. Bullen et al., “Recombinant human leptin in women with hypothalamic amenorrhea,” New England Journal of Medicine, vol. 351, no. 10, pp. 987–997, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. A. J. Mason, J. S. Hayflick, and R. T. Zoeller, “A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse,” Science, vol. 234, no. 4782, pp. 1366–1370, 1986. View at Scopus
56. A. J. Mason, S. L. Pitts, and K. Nikolics, “The hypogonadal mouse: reproductive functions restored by gene therapy,” Science, vol. 234, no. 4782, pp. 1372–1378, 1986. View at Scopus
57. J. Weiss, W. F. Crowley Jr., and J. L. Jameson, “Normal structure of the gonadotropin-releasing hormone (GnRH) gene in patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 2, pp. 299–303, 1989. View at Scopus
58. Y. Bo-Abbas, J. S. Acierno Jr., J. K. Shagoury, W. F. Crowley, and S. B. Seminara, “Autosomal recessive idiopathic hypogonadotropic hypogonadism: genetic analysis excludes mutations in the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2730–2737, 2003. View at Scopus
59. J. Bouligand, C. Ghervan, J. A. Tello et al., “Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation,” New England Journal of Medicine, vol. 360, no. 26, pp. 2742–2748, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
60. S. D. C. Bianco and U. B. Kaiser, “The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism,” Nature Reviews Endocrinology, vol. 5, no. 10, pp. 569–576, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. A. Lofrano-Porto, G. B. Barra, L. A. Giacomini et al., “Luteinizing hormone beta mutation and hypogonadism in men and women,” New England Journal of Medicine, vol. 357, no. 9, pp. 897–904, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. A. P. N. Themmen and I. T. Huhtaniemi, “Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function,” Endocrine Reviews, vol. 21, no. 5, pp. 551–583, 2000. View at Scopus
63. J. Weiss, L. Axelrod, R. W. Whitcomb, P. E. Harris, W. F. Crowley, and J. L. Jameson, “Hypogonadism caused by a single amino acid substitution in the β subunit of luteinizing hormone,” Obstetrical and Gynecological Survey, vol. 47, no. 6, pp. 416–418, 1992. View at Scopus
64. C. H. Matthews, S. Borgato, P. Beck-Peccoz et al., “Primary amenorrhoea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone,” Nature Genetics, vol. 5, no. 1, pp. 83–86, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. L. C. Layman, E. J. Lee, D. B. Peak et al., “Delayed puberty and hypogonadism caused by mutations in the follicle- stimulating hormone β-subunit gene,” New England Journal of Medicine, vol. 337, no. 9, pp. 607–611, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. L. C. Layman, A. L. A. Porto, J. Xie et al., “FSHβ gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3702–3707, 2002. View at Publisher · View at Google Scholar · View at Scopus
67. M. L. Kottler, Y. Y. Chou, O. Chabre et al., “A new FSHβ mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH,” European Journal of Endocrinology, vol. 162, no. 3, pp. 633–641, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
68. L. F. G. Silveira, G. S. MacColl, and P. M. G. Bouloux, “Hypogonadotropic hypogonadism,” Seminars in Reproductive Medicine, vol. 20, no. 4, pp. 327–338, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
69. M. Zitzmann and E. Nieschlag, “Hormone substitution in male hypogonadism,” Molecular and Cellular Endocrinology, vol. 161, no. 1-2, pp. 73–88, 2000. View at Publisher · View at Google Scholar · View at Scopus
70. F. P. Pralong, F. Gomez, E. Castillo et al., “Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 10, pp. 3811–3816, 1999. View at Scopus
71. L. C. Layman, P. G. McDonough, D. P. Cohen, M. Maddox, S. P. T. Tho, and R. H. Reindollar, “Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals,” Fertility and Sterility, vol. 75, no. 6, pp. 1148–1155, 2001. View at Publisher · View at Google Scholar · View at Scopus
72. S. B. Seminara, M. Beranova, L. M. B. Oliveira, K. A. Martin, W. F. Crowley, and J. E. Hall, “Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 2, pp. 556–562, 2000. View at Publisher · View at Google Scholar · View at Scopus
73. A. A. Dwyer, F. J. Hayes, L. Plummer, N. Pitteloud, and W. F. Crowley, “The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4235–4243, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
74. L. M. Caronia, C. Martin, C. K. Welt et al., “A genetic basis for functional hypothalamic amenorrhea,” New England Journal of Medicine, vol. 364, no. 3, pp. 215–225, 2011. View at Publisher · View at Google Scholar · View at PubMed
75. M. B. Ranke and H. G. Dörr, “Sex steroid replacement therapy in adolescents with hypogonadism. Expert workshop consensus,” Gynakologische Endokrinologie, vol. 7, no. 2, pp. 111–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
76. S. Drobac, K. Rubin, A. D. Rogol, and R. L. Rosenfield, “A Workshop on pubertal hormone replacement options in the United States,” Journal of Pediatric Endocrinology and Metabolism, vol. 19, no. 1, pp. 55–64, 2006. View at Scopus
77. W. Kiess, G. Conway, M. Ritzen et al., “Induction of puberty in the hypogonadal girl—practices and attitudes of pediatric endocrinologists in Europe,” Hormone Research, vol. 57, no. 1-2, pp. 66–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
78. T. Raivio, J. Toppari, A. Perheentupa, A. S. McNeily, and L. Dunkel, “Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone,” Lancet, vol. 350, no. 9073, pp. 263–264, 1997. View at Publisher · View at Google Scholar · View at Scopus
79. R. Barrio, D. De Luis, M. Alonso, A. Lamas, and J. C. Moreno, “Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism,” Fertility and Sterility, vol. 71, no. 2, pp. 244–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
80. D. Büchter, H. M. Behre, S. Kliesch, and E. Nieschlag, “Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases,” European Journal of Endocrinology, vol. 139, no. 3, pp. 298–303, 1998. View at Publisher · View at Google Scholar · View at Scopus
81. H. A. Delemarre-Van De Waal, “Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism—diagnostic and therapeutic aspects,” European Journal of Endocrinology, Supplement, vol. 151, no. 3, pp. U89–U94, 2004. View at Scopus
82. P. Y. Liu, H. W. G. Baker, V. Jayadev, M. Zacharin, A. J. Conway, and D. J. Handelsman, “Induction of spermatogenesis and fertility during gonadotropin treatment of Gonadotropin-Deficient infertile men: predictors of fertility outcome,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 3, pp. 801–808, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus